Table of Contents
International Scholarly Research Notices
Volume 2014, Article ID 675868, 9 pages
http://dx.doi.org/10.1155/2014/675868
Research Article

Sublingual Delivery of Frovatriptan: An Indication of Potential Alternative Route

School of Pharmaceutical Sciences, Lovely Faculty of Applied Medical Sciences, Lovely Professional University, Phagwara, Punjab 144411, India

Received 13 June 2014; Accepted 3 August 2014; Published 29 October 2014

Academic Editor: Romána Zelkó

Copyright © 2014 Hitesh Verma et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. J. Tepper and R. C. Spears, “Acute treatment of migraine,” Neurologic Clinics, vol. 27, no. 2, pp. 417–427, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. F. G. Freitag, “The cycle of migraine: patients' quality of life during and between migraine attacks,” Clinical Therapeutics, vol. 29, no. 5, pp. 939–949, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. P. J. Goadsby, “Migraine: diagnosis and management,” Internal Medicine Journal, vol. 33, no. 9-10, pp. 436–442, 2003. View at Publisher · View at Google Scholar · View at Scopus
  4. A. MaassenVanDenBrink and K. Y. Chan, “Neurovascular pharmacology of migraine,” European Journal of Pharmacology, vol. 585, no. 2-3, pp. 313–319, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. Meiyanti, “The role of triptans in the management of migraine,” Universa Medicina, vol. 28, no. 1, pp. 49–58, 2009. View at Google Scholar
  6. K. S. Dhillon, J. Singh, and J. S. Lyall, “A new horizon into the pathobiology, etiology and treatment of migraine,” Medical Hypotheses, vol. 77, no. 1, pp. 147–151, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. S. S. Jhee, T. Shiovitz, A. W. Crawford, and N. R. Cutler, “Pharmacokinetics and pharmacodynamics of the triptan antimigraine agents: a comparative review,” Clinical Pharmacokinetics, vol. 40, no. 3, pp. 189–205, 2001. View at Publisher · View at Google Scholar · View at Scopus
  8. M. M. Johnston and A. M. Rapoport, “Triptans for the management of migraine,” Drugs, vol. 70, no. 12, pp. 1505–1518, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. M. E. Bigal, A. V. Krymchantowski, and T. Ho, “Migraine in the triptan era: progresses achieved, lessons learned and future developments,” Arquivos de Neuro-Psiquiatria, vol. 67, no. 2B, pp. 559–569, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. A. D. Oldman, L. A. Smith, H. J. McQuay, and R. A. Moore, “Pharmacological treatments for acute migraine: quantitative systematic review,” Pain, vol. 97, no. 3, pp. 247–257, 2002. View at Publisher · View at Google Scholar · View at Scopus
  11. R. L. Hale, J. D. Rabinowitz, D. W. Solas, and A. C. Zaffaroni, “Delivery of sumatriptan, frovatriptan or naratriptan through inhalation route,” US 7005122 B2, 2006. View at Google Scholar
  12. J. F. Pinto, “Site-specific drug delivery systems within the gastro-intestinal tract: from the mouth to the colon,” International Journal of Pharmaceutics, vol. 395, no. 1-2, pp. 44–52, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. N. V. S. Madhav, A. K. Shakya, P. Shakya, and K. Singh, “Orotransmucosal drug delivery systems: a review,” Journal of Controlled Release, vol. 140, no. 1, pp. 2–11, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. O. Rachid, M. Rawas-Qalaji, F. E. R. Simons, and K. J. Simons, “Dissolution testing of sublingual tablets: a novel in vitro method,” AAPS PharmSciTech, vol. 12, no. 2, pp. 544–552, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. Z. Bayrak, U. Tasdemir, H. Erol, C. K. Ozkan, A. Savaser, and Y. Ozkan, “Formulation of zolmitriptan sublingual tablets prepared by direct compression with different polymers: in vitro and in vivo evaluation,” European Journal of Pharmaceutics and Biopharmaceutics, vol. 78, no. 3, pp. 499–505, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. S. Bredenberg, M. Duberg, B. Lennernäs et al., “In vitro and in vivo evaluation of a new sublingual tablet system for rapid oromucosal absorption using fentanyl citrate as the active substance,” European Journal of Pharmaceutical Sciences, vol. 20, no. 3, pp. 327–334, 2003. View at Publisher · View at Google Scholar · View at Scopus
  17. P. M. Young, “Sodium starch glycolate,” in Handbook of Pharmaceutical Excipients, R. C. Rowe, P. J. Sheskey, and M. E. Quinn, Eds., pp. 663–666, Pharmaceutical Press, London, UK, 6th edition, 2009. View at Google Scholar
  18. H. Verma, S. Verma, and H. Singh, “A stability indicating assay method development and validation for the frovatriptan succinate monohydrate by using UV: a spectrophotometric technique,” ISRN Spectroscopy, vol. 2013, Article ID 361385, 6 pages, 2013. View at Publisher · View at Google Scholar
  19. United States Pharmacopoeia—National Formulary, United States Pharmacopoeial Convention, Rockville, Md, USA, 2007.
  20. C. M. Setty, D. V. K. Prasad, V. R. M. Gupta, and B. Sa, “Development of fast dispersible aceclofenac tablets: effect of functionality of superdisintegrants,” Indian Journal of Pharmaceutical Sciences, vol. 70, no. 2, pp. 180–185, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. S. H. Jeong, Y. Takaishi, Y. Fu, and K. Park, “Material properties for making fast dissolving tablets by a compression method,” Journal of Materials Chemistry, vol. 18, no. 30, pp. 3527–3535, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. G. S. Banker and N. R. Anderson, “Tablets,” in The Theory and Practice of Industrial Pharmacy, L. Lachman, H. A. Lieberman, H. A. and, and J. L. Kanig, Eds., pp. 293–345, Varghese Publishing House, Bombay, India, 3rd edition, 1991. View at Google Scholar
  23. S. S. Ölmez and I. Vural, “Advantages and quality control of orally disintegrating tablets,” FABAD Journal of Pharmaceutical Sciences, vol. 34, no. 3, pp. 167–172, 2009. View at Google Scholar · View at Scopus
  24. E. M. Rudnic and J. D. Schwartz, “Oral solid dosage forms,” in Remington: the Science and Practice of Pharmacy, A. R. Gennaro, Ed., vol. 1, pp. 858–893, Lippincott Williams & Wilkins, Baltimore, Md, USA, 2006. View at Google Scholar
  25. A. Kajiyama, H. Takagi, K. Moribe, and K. Yamamoto, “Improvement of HPMC tablet disintegration by the addition of inorganic salts,” Chemical and Pharmaceutical Bulletin, vol. 56, no. 4, pp. 598–601, 2008. View at Publisher · View at Google Scholar · View at Scopus
  26. T. Ishikawa, Y. Watanabe, K. Takayama, H. Endo, and M. Matsumoto, “Effect of hydroxypropylmethylcellulose (HPMC) on the release profiles and bioavailability of a poorly water-soluble drug from tablets prepared using macrogol and HPMC,” International Journal of Pharmaceutics, vol. 202, no. 1-2, pp. 173–178, 2000. View at Publisher · View at Google Scholar · View at Scopus
  27. G. C. Ritthidej, P. Chomto, S. Pummangura, and P. Menasveta, “Chitin and chitosan as disintegrants in paracetamol tablets,” Drug Development and Industrial Pharmacy, vol. 20, no. 13, pp. 2109–2134, 1994. View at Publisher · View at Google Scholar · View at Scopus
  28. Y. Sudhakar, K. Kuotsu, and A. K. Bandyopadhyay, “Buccal bioadhesive drug delivery—a promising option for orally less efficient drugs,” Journal of Controlled Release, vol. 114, no. 1, pp. 15–40, 2006. View at Publisher · View at Google Scholar · View at Scopus
  29. T. Goswami, B. R. Jasti, and X. Li, “Estimation of the theoretical pore sizes of the porcine oral mucosa for permeation of hydrophilic permeants,” Archives of Oral Biology, vol. 54, no. 6, pp. 577–582, 2009. View at Publisher · View at Google Scholar · View at Scopus
  30. T. Goswami, A. Kokate, B. R. Jasti, and X. Li, “In silico model of drug permeability across sublingual mucosa,” Archives of Oral Biology, vol. 58, no. 5, pp. 545–551, 2013. View at Publisher · View at Google Scholar · View at Scopus
  31. C. M. Y. Ong and C. M. Heard, “Permeation of quinine across sublingual mucosa, in vitro,” International Journal of Pharmaceutics, vol. 366, no. 1-2, pp. 58–64, 2009. View at Publisher · View at Google Scholar · View at Scopus
  32. L. M. Collins and C. Dawes, “The surface area of the adult human mouth and thickness of the salivary film covering the teeth and oral mucosa,” Journal of Dental Research, vol. 66, no. 8, pp. 1300–1302, 1987. View at Google Scholar · View at Scopus